AgingResearch.News
Diabetes, Obesity & Metabolism

Comparative Cardiorenal Efficacy and Safety of Finerenone, SGLT2 Inhibitors, Semaglutide and Their Combination in Diabetic Kidney Disease

By Ziyan Zhou, Linghua Fu, Dan Chen, Show 4 more authorsPingping Yang
Meta-analysis of randomised trialsInterventions
Paper

The paper

Ziyan Zhou, Linghua Fu, Dan Chen, Show 4 more authorsPingping Yang

Nanchang University

Diabetes, Obesity & Metabolism, 17 Sep 2026

doi.org/10.1111/dom.71305PubMed 42750649

More on Type 2 diabetes